To help manage your website's hosting, DNS, security, and performance, SiteCare may request access to your Cloudflare account.
Follow these instructions to invite support@sitecare.com as a member with Super Administrator permissions. You won't need to share your Cloudflare password.
Granting Cloudflare Access to SiteCare Support
Step 1: Log In to Cloudflare
- Visit dash.cloudflare.com.
- Log in to your Cloudflare account.
- If you don't have an account, you can create one for free.
Step 2: Navigate to Members
- Select the Cloudflare account associated with your website.
- In the account navigation, select Members, under Manage Account.
Step 3: Invite a New Member
- Click Invite members.
-
Under Add email addresses, enter:
Step 4: Assign Permissions
Under Add permission policies:
- Set the scope to Entire Account.
- Search for and select Super Administrator - All Privileges.
- Click Create policy.
These permissions allow SiteCare to configure your DNS, security settings, caching, and other Cloudflare services needed to manage your website.
Important: Super Administrator access provides full administrative control over the Cloudflare account, including billing and member management. If you have multiple websites in the same Cloudflare account, these permissions will apply to all of them.
Step 5: Send the Invitation
- Review the email address and permissions.
- Click Invite members to send the invitation.
- Cloudflare will email an invitation to the SiteCare support team.
Step 6: Confirm Access
After sending the invitation, you should see support@sitecare.com listed on the Members page with a Pending status.
Once our team accepts the invitation, the status will update.
You're All Set!
SiteCare will receive your invitation and can begin configuring your Cloudflare account as part of your website onboarding or hosting migration.
If you have any questions or run into trouble, please contact SiteCare Support.
For additional information, see Cloudflare's official documentation on managing account members.
Comments
0 comments
Article is closed for comments.